Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
70%
OVERLAP
BY WEIGHT
60
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
100%
ALSO IN IXJ
IXJ
114
HOLDINGS
54%
ALSO IN XLV
SECTOR DRIFT (XLV minus IXJ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 14.7% | 10.4% | 10.4% | |
| JOHNSON & JOHNSON | 10.1% | 7.1% | 7.1% | |
| ABBVIE INC | 6.9% | 4.9% | 4.9% | |
| MERCK & CO. INC. | 5.3% | 3.7% | 3.7% | |
| UNITEDHEALTH GROUP INC | 4.4% | 3.1% | 3.1% | |
XLV Overweight Relative to IXJ
| ELI LILLY & CO | 4.3% | |
| JOHNSON & JOHNSON | 3.0% | |
| ABBVIE INC | 2.0% | |
| MERCK & CO. INC. | 1.6% | |
| UNITEDHEALTH GROUP INC | 1.3% | |
| AMGEN INC | 1.1% | |
| THERMO FISHER SCIENTIFIC INC | 1.0% | |
| ABBOTT LABORATORIES | 1.0% | |
| GILEAD SCIENCES INC | 1.0% | |
| INTUITIVE SURGICAL INC | 0.9% |
XLV Underweight Relative to IXJ
| ROCHE HOLDING LTD | -4.0% | |
| ASTRAZENECA PLC | -3.6% | |
| NOVARTIS AG | -3.6% | |
| NOVO NORDISK A/S-B | -1.8% | |
| GSK PLC | -1.5% | |
| SANOFI-AVENTIS | -1.3% | |
| ESSILOR INTERNATIONAL | -1.1% | |
| CSL LIMITED | -0.8% | |
| HOYA CORP | -0.7% | |
| TAKEDA PHARMACEUTICAL CO LTD | -0.7% |